Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | EPRX.TO | HELP.NE | ||
| Company | Nervgen Pharma Corp | Eupraxia Pharmaceuticals Inc | Cybin Inc. | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | Cboe CA | ||
| Open | 4.950 | 10.20 | 7.6000 | ||
| High | 5.230 | 10.20 | 7.6100 | ||
| Low | 4.930 | 9.85 | 7.4900 | ||
| Latest | 5.150 | 10.03 | 7.5700 | ||
| Change | +0.150 | +0.02 | -0.0300 | ||
| % Change | +3.00% | +0.20% | -0.39% | ||
| Volume | 66,939 | 33,763 | 6,230 | ||
| 20-Day Average Volume | 49,920 | 58,245 | 11,511 | ||
| Previous Close | 5.000 | 10.01 | 7.6000 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 9.81 | 6.8573 | ||
| 20-Day Raw Stochastic | 23.73% | 61.33% | 90.27% | ||
| 20-Day Relative Strength | 42.10 | 48.31 | 49.02 | ||
| Weighted Alpha | +39.45 | +89.26 | N/A | ||
| Today's Opinion | 8% Buy | 24% Buy | N/A | ||
| Previous Opinion | 24% Buy | 24% Buy | N/A | ||
| Last Month's Opinion | 40% Buy | 40% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | +6.03% since 04/08/26 | +3.98% since 04/08/26 | ||
| Low | 4.870 on 03/13/26 | 9.34 on 04/09/26 | 7.1000 on 04/09/26 | ||
| High | 5.700 on 03/10/26 | 10.61 on 04/13/26 | 7.7500 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | -1.18% since 03/13/26 | +18.28% since 03/13/26 | ||
| Low | 4.870 on 03/13/26 | 9.11 on 04/08/26 | 5.9000 on 03/31/26 | ||
| High | 6.050 on 02/23/26 | 10.91 on 03/17/26 | 7.7500 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | -19.11% since 01/15/26 | -31.12% since 01/15/26 | ||
| Low | 4.870 on 03/13/26 | 9.11 on 04/08/26 | 5.9000 on 03/31/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 11.6100 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +18.28% since 10/15/25 | N/A since 01/05/26 | ||
| Low | 3.200 on 11/06/25 | 7.35 on 11/07/25 | 5.9000 on 03/31/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 12.1200 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 615,647 | 379,268 | ||
| Shares Outstanding, K | 79,213 | 61,503 | 49,894 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -44,117,305 | -38,576,143 | -79,055,419 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -26,908,856 | -16,711,252 | -42,668,000 | ||
| 60-Month Beta | 0.54 | 1.54 | 0.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | -0.37 | -1.00 on 02/13/26 | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||